| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |